In addition to PKCδ and ε as potential therapeutic targets for glioblastoma, PKCζ may be a therapeutic target for glioblastoma cell migration and invasion [94], and PKCη may be a therapeutic target for glioblastoma proliferation [95,96]. Here, PRKCD is linked to glioblastoma.